Profile: Exact Sciences Corporation focuses on the detection and prevention of colorectal cancer. We provide stool-based DNA technology for screening colorectal cancer, that develops & arises from molecular alterations in multiple genes within an individual cell. Our stool-based DNA screening test is prescribed by healthcare providers for detecting colorectal cancer.
The company was founded in 1995, has revenues of < USD 1 Million, has ~10 employees. NASDAQ:EXAS (SEC Filings)
FDA Registration Number: 3013841562
2 Products/Services (Click for related suppliers)
|
• Cancer Detection Test |
• DNA Testing |